Novocure Ltd (NASDAQ:NVCR)

109.01
Delayed Data
As of Sep 29
 +0.68 / +0.63%
Today’s Change
53.40
Today|||52-Week Range
110.98
+29.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$10.8B

Company Description

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Contact Information

Novocure Ltd.
No. 4 The Forum
St. Helier Jersey JE2 4UF
P:441534756700
Investor Relations:

Employees

Shareholders

Mutual fund holders41.58%
Individual stakeholders36.23%
Other institutional27.87%

Top Executives

Asaf DanzigerChief Executive Officer & Director
Mike AmbrogiChief Operating Officer
Wilco GroenhuysenChief Financial Officer
Uri WeinbergVice President-Clinical Development
Ely BenaimChief Medical Officer